New drug regimen is safe and effective in children with cystic fibrosis
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of
Read more
Expert insights from collaborative and commercial microbiome research studies
Welcome to Expert insights: from Collaborative and Commercial Microbiome Research Studies Image Credit: Atlantia Clinical Trials This webinar series is
Read more
People diagnosed with alpha-1 antitrypsin deficiency more likely to stop smoking, study shows
New research shows that people diagnosed with a genetic condition, called alpha-1 antitrypsin deficiency (AATD), are far more likely to
Read more
Researchers identify 'violent' physical processes which cause wheezing
A team of engineers has identified the 'violent' physical processes at work inside the lungs which cause wheezing, a condition
Read more
How research on chronic illnesses will improve COVID-19 treatment
A new paper in Oxford Open Immunology, published by Oxford University Press, examines prior findings in the field of neuroimmunology
Read more
Long-Haul Covid Cases Cast New Light on Chronic Fatigue Sufferers
Four weeks after San Diego pediatric nurse Jennifer Minhas fell ill with covid-19 last March, her cough and fever had
Read more
Perspective: Why opioids cannot fix chronic pain
A broken heart is often harder to heal than a broken leg. Now researchers say that a broken heart can
Read more
Novartis Investigational STAMP Inhibitor Asciminib (ABL001) Shows Superior MMR Rate to Bosulif®* in Chronic Myeloid Leukemia Trial
EAST HANOVER, N.J., Dec. 8, 2020 /PRNewswire/ — Detailed results from the Phase III ASCEMBL study demonstrate that, at 24 weeks, asciminib (ABL001)
Read more
Researchers discover inhibitor for chronic obstructive pulmonary disease
Recently, a research team led by Profs. Liu Qingsong and Liu Jing from the Institute of Health & Medical Technology
Read more
COVID-19 a double blow for chronic disease patients
There has never been a more dangerous time than the COVID-19 pandemic for people with non-communicable diseases (NCDs) such as
Read more